Evidence for two conductive pathways in P2X7 receptor: Differences in modulation and selectivity

Journal of Neurochemistry

Volumn 113, Issue 3, 2010, Pages 796-806

  Alloisio, Susanna ^a   Di Garbo, Angelo ^b   Barbieri, Raffaella ^a   Bozzo, Luigi ^a   Ferroni, Stefano ^c   Nobile, Mario ^a  

^a CNR   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arachidonic acid; C terminal truncated P2X7 receptor; Extracellular magnesium; Ionic permeability; P2X7 purinoceptor

Indexed keywords

ARACHIDONIC ACID; CALCIUM ION; MAGNESIUM ION; PURINERGIC P2X7 RECEPTOR; SODIUM ION;

ARTICLE; CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; ION CURRENT; NERVE CONDUCTION; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN VARIANT; WHOLE CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; CALCIUM SIGNALING; CELL LINE; CYTOPHOTOMETRY; ELECTROPHYSIOLOGY; HUMANS; MAGNESIUM; NEURAL CONDUCTION; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SODIUM CHANNELS; TRANSFECTION;

EID: 77950684528     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06649.x     Document Type: Article

References (45)

1. 7 purinergic receptor. J. Neurochem. 101, 17 26.
2. 7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Mol. Pharmacol. 69, 1975 1983.
3. Barrera N. P., Ormond S. J., Henderson R. M., Murrell-Lagnado R. D. Edwardson J. M. (2005) Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J. Biol. Chem. 280, 10759 10765.
4. 7 receptor channel activity. J. Biol. Chem. 283, 25725 25734.
5. Cankurtaran-Sayar S., Sayar K. Ugur M. (2009) P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264.7 and human embryonic kidney 293 cells. Mol. Pharmacol. 76, 1323 1332.
6. Chaumont S. Khakh B. S. (2008) Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels. Proc. Natl Acad. Sci. USA 105, 12063 12068.
7. 7 receptor. FEBS Lett. 439, 26 30.
8. Di Virgilio F. (2007) Purinergic signalling in the immune system. A brief update. Purinergic Signal. 3, 1 3.
9. Di Virgilio F., Borea P. A. Illes P. (2001) P2 receptors meet the immune system. Trends Pharmacol. Sci. 22, 5 7.
10. Ding S. Sachs F. (2000) Inactivation of P2X2 purinoceptors by divalent cations. J. Physiol. 522, 199 214.
11. Duan S. Neary J. T. (2006) P2X(7) receptors: properties and relevance to CNS function. Glia 54, 738 746.
12. 7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 23, 1320 1328.
13. Egan T. M., Samways D. S. Li Z. (2006) Biophysics of P2X receptors. Pflugers Arch. 452, 501 512.
14. 7 receptor: a key player in IL-1 processing and release. J. Immunol. 176, 3877 3883.
15. Fischer W., Franke H., Gröger-Arndt H. Illes P. (2005) Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application. Naunyn Schmiedebergs Arch. Pharmacol. 371, 466 472.
16. Franke H., Krügel U., Schmidt R., Grosche J., Reichenbach A. Illes P. (2001) P2 receptor-types involved in astrogliosis in vivo. Br. J. Pharmacol. 134, 1180 1189.
17. Franke H., Schepper C., Illes P. Krügel U. (2007) Involvement of P2X and P2Y receptors in microglial activation in vivo. Purinergic Signal. 3, 435 445.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440 3450.
19. Hamilton N., Vayro S., Kirchhoff F., Verkhratsky A., Robbins J., Gorecki D. C. Butt A. M. (2008) Mechanisms of ATP- and glutamate-mediated calcium signaling in white matter astrocytes. Glia 56, 734 749.
20. + in Individual fibroblasts and lynphocytes. J. Biol. Chem. 264, 19458 19467.
21. Jiang L. H. (2009) Inhibition of P2X(7) receptors by divalent cations: old action and new insight. Eur. Biophys. J. 38, 339 346.
22. Kawate T., Michel J. C., Birdsong W. T. Gouaux E. (2009) Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460, 592 598.
23. Klapperstück M., Büttner C., Schmalzing G. Markwardt F. (2001) Functional evidence of distinct ATP activation sites at the human P2X(7) receptor. J. Physiol. 534, 25 35.
24. Koshimizu T. A., Van Goor F., Tomic M., Wong A. O., Tanoue A., Tsujimoto G. Stojilkovic S. S. (2000) Characterisation of calcium signalling by purinergic receptor-channels expressed in excitable cells. Mol. Pharmacol. 58, 936 945.
25. Li C., Peoples R. W. Weight F. F. (1997) Enhancement of ATP-activated current by protons in dorsal root ganglion neurons. Pflugers Arch. 433, 446 454. (Pubitemid 27065332)
26. Locovei S., Scemes E., Qiu F., Spray D. C. Dahl G. (2007) Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 581, 483 488.
27. Ma W., Korngreen A., Weil S., Cohen E. B., Priel A., Kuzin L. Silberberg S. D. (2006) Pore properties and pharmacological features of the P2X receptor channel in airway ciliated cells. J. Physiol. 571, 503 517.
28. 7 presynaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release. J. Neurochem. 105, 2330 2342.
29. McLarnon J. G., Ryu J. K., Walker D. G. Choi H. B. (2006) Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65, 1090 1097.
30. 7 receptor function. Naunyn Schmiedebergs Arch. Pharmacol. 359, 102 109.
31. 7 receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons. Neurosci. Lett. 446, 45 50.
32. Nicke A., Bäumert H. G., Rettinger J., Eichele A., Lambrecht G., Mutschler E. Schmalzing G. (1998) P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 17, 3016 3028.
33. 7-like-mediated calcium entry. FEBS Lett. 538, 71 76.
34. 7. EMBO J. 25, 5071 5082.
35. Pelegrin P. Surprenant A. (2007) Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282, 2386 2394.
36. 7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype. FEBS Lett. 411, 339 345.
37. Schachter J., Motta A. P., de Souza Zamorano A., da Silva-Souza H. A., Guimarães M. Z. Persechini P. M. (2008) ATP-induced P2X7-associated uptake of large molecules involves distinct mechanisms for cations and anions in macrophages. J. Cell Sci. 121, 3261 3270.
38. 7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278, 8853 8860.
39. 7 receptors in the nervous system. Prog. Neurobiol. 78, 327 346.
40. 7). Science 272, 735 738.
41. 7 receptor. Neuropharmacology 36, 1285 1294.
42. 7 receptor. J. Physiol. 519, 335 346.
43. 7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10, 821 827.
44. 7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia. Glia 57, 307 319.
45. 7 receptor channel pore dilates under physiological ion conditions. J. Gen. Physiol. 132, 563 573.